Literature DB >> 11708786

Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema.

N Minematsu1, H Nakamura, H Tateno, T Nakajima, K Yamaguchi.   

Abstract

Protease-antiprotease imbalance due to genetic variation may be responsible for the development of pulmonary emphysema induced by smoking. Since matrix metalloproteinases (MMPs) have recently been suggested to play important roles in the pathogenesis of pulmonary emphysema, the association between the functional polymorphism of MMP-9 (-1562C/T) and the development of pulmonary emphysema was examined in 110 smokers and 94 nonsmokers in Japan. The T allele frequency was higher in subjects with distinct emphysema on chest CT-scans (n = 45) than in those without it (n = 65) (0.244 vs 0.123, P = 0.02). Logistic regression analysis demonstrated that the T allele is a risk factor for smoking-induced emphysema (odds ratio = 2.69, P = 0.02). DL(CO)/VA was lower (P = 0.02) and emphysematous changes were more conspicuous (P = 0.03) in subjects with C/T or T/T (n = 35) than in those with C/C (n = 75). These results suggest that the polymorphism of MMP-9 acts as a genetic factor for the development of smoking-induced pulmonary emphysema. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708786     DOI: 10.1006/bbrc.2001.5936

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

Review 1.  Chronic obstructive pulmonary disease - part 2: pathology and biochemistry of emphysema.

Authors:  J C Hogg; R M Senior
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

Review 2.  Matrix metalloproteinases in emphysema.

Authors:  Sina A Gharib; Anne M Manicone; William C Parks
Journal:  Matrix Biol       Date:  2018-03-23       Impact factor: 11.583

3.  The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema.

Authors:  Jeffrey J Atkinson; Barbara A Lutey; Yoko Suzuki; Holly M Toennies; Diane G Kelley; Dale K Kobayashi; Whitney G Ijem; Gaetan Deslee; Carla H Moore; M Eileen Jacobs; Susan H Conradi; David S Gierada; Richard A Pierce; Tomoko Betsuyaku; Robert M Senior
Journal:  Am J Respir Crit Care Med       Date:  2010-11-05       Impact factor: 21.405

4.  Molecular mechanisms of MMP9 overexpression and its role in emphysema pathogenesis of Smad3-deficient mice.

Authors:  Bing Xu; Hui Chen; Wei Xu; Wenming Zhang; Sue Buckley; Song Guo Zheng; David Warburton; Martin Kolb; Jack Gauldie; Wei Shi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-05-18       Impact factor: 5.464

5.  A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women.

Authors:  F Lose; P J Thompson; D Duffy; G A Stewart; M-A Kedda
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

Review 6.  National Emphysema Treatment Trial state of the art: genetics of emphysema.

Authors:  Craig P Hersh; Dawn L DeMeo; Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

7.  MMP9 modulates tight junction integrity and cell viability in human airway epithelia.

Authors:  Paola D Vermeer; James Denker; Miriam Estin; Thomas O Moninger; Shaf Keshavjee; Philip Karp; Joel N Kline; Joseph Zabner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-06       Impact factor: 5.464

Review 8.  Genetics of chronic obstructive pulmonary disease.

Authors:  Carola Seifart; Alexandra Plagens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

9.  Chronic obstructive pulmonary disease: towards pharmacogenetics.

Authors:  Alice M Wood; See Ling Tan; Robert A Stockley
Journal:  Genome Med       Date:  2009-11-30       Impact factor: 11.117

10.  Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.

Authors:  Imran Haq; Sally Chappell; Simon R Johnson; Juzer Lotya; Leslie Daly; Kevin Morgan; Tamar Guetta-Baranes; Josep Roca; Roberto Rabinovich; Ann B Millar; Seamas C Donnelly; Vera Keatings; William MacNee; Jan Stolk; Pieter S Hiemstra; Massimo Miniati; Simonetta Monti; Clare M O'Connor; Noor Kalsheker
Journal:  BMC Med Genet       Date:  2010-01-15       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.